N. Xiros

A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1/IRF4

Serena Valsami, Vasiliki Pappa, Dimitra Rontogianni et al. · Haematologica · 2007 · 44 citations · Full text

Medicine, Oncology, Pathology +17

Monoclonal gammopathies in B-cell non-Hodgkin’s lymphomas

T. Economopoulos, Sotirios G. Papageorgiou, Vasiliki Pappa et al. · Leukemia Research · 2003 · 41 citations

Medicine, Oncology, Pathology +8

Carboplatin and Paclitaxel in Metastatic or Recurrent Cervical Cancer

Dimitrios Pectasides, George Fountzilas, George Papaxoinis et al. · International Journal of Gynecological Cancer · 2009 · 40 citations

Medicine, Oncology, Pharmacology +17

Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study

Evangelos Briasoulis, George Fountzilas, Aristotelis Bamias et al. · Cancer Chemotherapy and Pharmacology · 2007 · 27 citations

Medicine, Oncology, Pharmacology +13

CEOP-21 Versus CEOP-14 Chemotherapy With or Without Rituximab for the First-Line Treatment of Patients With Aggressive Lymphomas: Results of the HE22A99 Trial of the Hellenic Cooperative Oncology Group

T. Economopoulos, A. Psyrri, Meletios Α. Dimopoulos et al. · The Cancer Journal · 2007 · 17 citations

Medicine, Oncology, Pharmacology +12